Hani M. Jneid
The University of Texas Medical Branch at Galveston1 paperORCID 0000-0002-8754-358XOpenAlex
Papers
Diabetes & Vascular Disease ResearchHumans
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Older adults taking GLP-1 agonists showed higher risks of Alzheimer's disease (RR 1.33) and all-cause mortality (RR 1.11) than those on SGLT2…Older adults taking GLP-1 agonists showed higher risks of Alzheimer's disease (RR 1.33) and all-cause mortality (RR 1.11) than those on SGLT2 inhibitors.